Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Campylobacter vaccine completes phase II trial

June 17, 1999

Stable immunomodulators related to Imreg-1 developed at BioChem Pharma

June 17, 1999

U.S. patent granted for conjugate vaccine against group B streptococci

June 17, 1999

Aviron completes FluMist bridging study

June 16, 1999

NAVA's novel meningococcal vaccine elicits immunologic memory

June 16, 1999

New PTK inhibitors developed at Bristol-Myers Squibb

June 15, 1999

FDA approves initiation of clinical trial of strep vaccine

June 15, 1999

Japanese lab discloses inhibitors of STAT6 activation

June 14, 1999

Amrad reports disappointing results of phase II trial evaluating RSV vaccine

June 11, 1999

Tresperimus for the treatment of GvHD in bone marrow transplant recipients

June 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...